Scalper1 News
Shares of biotech The Medicines Co. (MDCO) jumped Wednesday on a report that the company is exploring a sale. Bloomberg cited anonymous sources in its report early Wednesday, which did not name a potential buyer. Medicines Co.’s financials have been suffering lately due to the loss of patent exclusivity on lead drug Angiomax, but the stock has stayed relatively buoyant due to hopes for cholesterol drug candidate ALN-PCSsc, which it is developing Scalper1 News
Scalper1 News